Drug Type Small molecule drug |
Synonyms Gemcitabine prodrug/Cedazuridine, LR 06, LR 06B + [1] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Preclinical | Canada | 01 Sep 2025 | |
| Breast Cancer | Preclinical | Switzerland | 30 Nov 2022 | |
| Ovarian Cancer | Preclinical | Switzerland | 30 Nov 2022 | |
| Pancreatic Cancer | Preclinical | Switzerland | 30 Nov 2022 |





